COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING THEIR FIRST BIOLOGIC IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)

被引：0

作者：

Narayanan, S. ^{[1
]}

Lu, Y. ^{[2
]}

Hutchings, R. ^{[2
]}

Baskett, A. ^{[2
]}

机构：

[1] Ipsos Healthcare, Columbia, MD USA

[2] Ipsos Healthcare, London, England

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

10.1016/j.jval.2013.03.1110

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A219 / A219

页数：1

共 44 条

[1] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING THEIR FIRST BIOLOGIC IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)
Narayanan, S.
Lu, Y.
Hutchings, R.
Baskett, A.
VALUE IN HEALTH, 2013, 16 (03) : A218 - A219
[2] COMPARISON OF CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) RECEIVING THEIR FIRST BIOLOGIC IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)
Narayanan, S.
Lu, Y.
Hutchings, R.
Baskett, A.
VALUE IN HEALTH, 2013, 16 (03) : A229 - A229
[3] IMPACT OF DISEASE SEVERITY ON DURATION OF USE OF FIRST BIOLOGIC AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)
Narayanan, S.
Lu, Y.
Hutchings, R.
Baskett, A.
VALUE IN HEALTH, 2014, 17 (03) : A53 - A54
[4] IMPACT OF DISEASE SEVERITY ON DURATION OF USE OF FIRST BIOLOGIC AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN UK, GERMANY, FRANCE, ITALY AND SPAIN
Narayanan, S.
Lu, Y.
Hutchings, R.
Baskett, A.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 483 - 483
[5] COMPARISON OF DISEASE STATUS, TREATMENTS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THEIR FIRST BIOLOGIC IN THE EUROPEAN UNION AND UNITED STATES
Narayanan, S.
Baskett, A.
Lu, Y.
Hutchings, R.
VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
[6] COMPARISON OF TREATMENT PATTERNS AND DISEASE SEVERITY AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING THEIR FIRST BIOLOGIC, TREATED BY RHEUMATOLOGISTS AND DERMATOLOGISTS IN EUROPE (EU)
Narayanan, S.
Hautamaki, E.
Lu, Y.
Franceschetti, A.
VALUE IN HEALTH, 2014, 17 (07) : A542 - A542
[7] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
Narayanan, S.
Lu, Y.
Hutchings, R.
Baynton, E.
VALUE IN HEALTH, 2014, 17 (07) : A373 - A373
[8] Impact of increasing disease symptom concordance between patients with inflammatory bowel disease and their physicians: insights from US, France, Germany, Italy, Spain and UK (5EU)
Kershaw, J.
Wild, R.
Lukanova, R.
Wirta, S. Bruce
Sikirica, M.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S142 - S142
[9] Variations in treatment patterns, disease status and outcomes among patients with psoriatic arthritis receiving their first biologic in European union
Narayanan, S.
Baskett, A.
Lu, Y.
Hutchings, R.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 54 - 54
[10] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN THE UNITED STATES (US)
Narayanan, S.
Lu, Y.
Hutchings, R.
Baynton, E.
VALUE IN HEALTH, 2015, 18 (03) : A1555 - A1555

← 1 2 3 4 5 →